Search Within

Aviva J Goel

Formats
  1. Journal Article (6)
  2. Meeting Abstract (1)
Groups
  1. GSK Faculty (6)
  2. Human Oncology and Pathogenesis Program (6)
  3. Department of Medicine (5)
  4. Tow Center for Developmental Oncology (TCDO) (5)
  5. Adult Leukemia (4)
  6. Biostatistics Service (4)

More Groups

People
  1. Priya Koppikar (4)
  2. Ross Levine (4)
  3. Neha Bhagwat (3)
  4. Omar Abdel-Wahab (3)
  5. Sachie Marubayashi (3)
  6. Abby Weinstein (2)

More People

Years
  1. 2012 (2)
  2. 2011 (1)
  3. 2010 (1)
  4. 2009 (3)
Publications
  1. Blood (2)
  2. Cancer Discovery (1)
  3. Journal of Clinical Investigation (1)
  4. Nature (1)
  5. PLoS ONE (1)
  6. Proceedings of the National Academy of Sciences of the United States of America (1)
Publishers
  1. American Society of Hematology (2)
  2. American Association for Cancer Research (1)
  3. American Society for Clinical Investigation (1)
  4. National Academy of Sciences (1)
  5. Nature Publishing Group (1)
  6. Public Library of Science (1)

Results (7)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Heterodimeric JAK STAT activation as a mechanism of persistence to JAK2 inhibitor therapy
    Journal Article

    Koppikar, P.; Bhagwat, N.; Kilpivaara, O.; Manshouri, T.; Adli, M.; Hricik, T.; Liu, F.; Saunders, L. M.; Mullally, A.; Abdel-Wahab, O.; more...
    Nature (2012)

    Fulltext@MSK | Save
  • Modulation of activation-loop phosphorylation by JAK inhibitors is binding mode dependent
    Journal Article

    Andraos, R.; Qian, Z.; Bonenfant, D.; Rubert, J.; Vangrevelinghe, E.; Scheufler, C.; Marque, F.; Régnier, C. H.; De Pover, A.; Ryckelynck, H.; more...
    Cancer Discovery (2012)

    Fulltext@MSK | Save
  • Heterodimeric JAK-STAT activation as a mechanism of persistence to JAK2 inhibitor therapy
    Meeting Abstract

    Bhagwat, N.; Koppikar, P.; Kilpivaara, O.; Manshouri, T.; Adli, M.; Mullally, A.; Abdel-Wahab, O.; Leung, L.; Weinstein, A.; Marubayashi, S.; more...
    Blood (2011)

    Fulltext@MSK | Save
  • Efficacy of the JAK2 inhibitor INCB16562 in a murine model of MPLW515L-induced thrombocytosis and myelofibrosis
    Journal Article

    Koppikar, P.; Abdel-Wahab, O.; Hedvat, C.; Marubayashi, S.; Patel, J.; Goel, A.; Kucine, N.; Gardner, J. R.; Combs, A. P.; Vaddi, K.; more...
    Blood (2010)

    Fulltext@MSK | Save
  • Identifying genotype-dependent efficacy of single and combined PI3K- and MAPK-pathway inhibition in cancer
    Journal Article

    Sos, M. L.; Fischer, S.; Ullrich, R.; Peifer, M.; Heuckmann, J. M.; Koker, M.; Heynck, S.; Stückrath, I.; Weiss, J.; Fischer, F.; more...
    Proceedings of the National Academy of Sciences of the United States of America (2009)

    Fulltext@MSK | Save
  • Dual targeting of EGFR can overcome a major drug resistance mutation in mouse models of EGFR mutant lung cancer
    Journal Article

    Regales, L.; Gong, Y.; Shen, R.; de Stanchina, E.; Vivanco, I.; Goel, A.; Koutcher, J. A.; Spassova, M.; Ouerfelli, O.; Mellinghoff, I. K.; more...
    Journal of Clinical Investigation (2009)

    Fulltext@MSK | Save
  • High expression levels of total IGF-1R and sensitivity of NSCLC cells in vitro to an anti-lGF-1R antibody (R1507)
    Journal Article

    Gong, Y.; Yao, E.; Shen, R.; Goel, A.; Arcila, M.; Teruya-Feldstein, J.; Zakowski, M. F.; Frankel, S.; Peifer, M.; Thomas, R. K.; more...
    PLoS ONE (2009)

    Fulltext@MSK | Save